Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases

Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases

US Patent 11041000 · Granted Jun 22, 2021

Estimated economic value: $31,200,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lipidated peptide inhibitors of interleukin-23 receptor2025
Lipidated peptide inhibitors of interleukin-23 receptor2025
Salts and polymorphs of cethromycin for the treatment of disease2025
Hepcidin analogues and uses thereof2025
Conjugated hepcidin mimetics2025
Conjugated hepcidin mimetics2025
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammator2024
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammator2024
Compositions of peptide inhibitors of Interleukin-23 receptor2024
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflam2024
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflam2024
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammator2023